pliantrx.com (PLRX) Quarterly EPS earnings growth

Symbol and logo of brand pliantrx.com (PLRX)

The quarterly EPS growth rate helps identify seasonal profit cycles, and its current value is 8.10. High barriers to entry in the fibrosis sector are ensured by patents and costly multi-year trials. The team at Pliant Therapeutics (PLRX) enjoys market confidence, while an academic approach to R&D is supported by generous stock option programs to retain rare specialists.

PLRX: Pliant Therapeutics, Inc. Year-over-year earnings per one share growth for the last 12 months 07/04/2022 - 11/16/2026

pliantrx.com (PLRX) - metric breakdowns and financial figures

- share price and expert price forecast:
Initial company analysis:Pliant Therapeutics
Flagship merchandise of Pliant Therapeutics

Pliant Therapeutics (PLRX) maintains liquidity through strategic partnerships with pharmaceutical behemoths, enabling the funding of fibrosis research without depleting capital. By analyzing quarterly earnings per share (EPS) dynamics, an investor assesses the rate of change in net income over three months, where any fundamental contraction of the metric signals loss risks and a decline in the company's business model efficiency.

Who Pliant Therapeutics competes with

VRTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alnylam Inc. (ALNY)|INSM (Insmed) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months UTHR (United Therapeutics Corporation)|Year-over-year net earnings per share growth for the last 12 months BMRN (BioMarin)|BBIO (BridgeBio Pharma) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth BGM (BGM Group Ltd)|COGT (Cogent Bio) - Year-over-year net earnings per share trend for the last twelve months|Xeris Biopharma - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months KROS (Keros Therapeutics)|ARCT: Quarterly EPS earnings growth|Eton Pharmaceuticals Inc (ETON) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Kamada Corp|FULC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Abeona Therapeutics, Inc. (ABEO)|Year-over-year net earnings per share growth for the last 12 months Mereo BioPharma Group plc MREO|Year-over-year earnings per share growth for the last twelve months Protalix BioTherapeutics PLX|Quarterly EPS earnings growth Applied Therapeutics APLT|RNTX - Year-over-year earnings per share growth for the last twelve months|Net earnings per share growth for the trailing year gelteq.com (GELS)|AYTU (aytubio.com) - Year-over-year net earnings per share growth for the last 12 months|Chemomab Therapeutics Ltd - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SRXH|Year-over-year earnings per share growth for the last twelve months PLRZ|Quarterly EPS earnings growth AEZS|Year-over-year earnings per share growth for the last twelve months CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Year-over-year net earnings per share growth for the last 12 months|Reneo Pharmaceuticals, Inc. (RPHM) - Earnings per share growth in annualized terms for the last twelve months|COSCIENS Bio - Quarterly EPS earnings growth